4519 — Chugai Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Chugai Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	157,560	214,733	302,995	374,429	325,472
Depreciation
Amortisation
Non-Cash Items	62,960	92,641	133,165	167,061	101,347
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-40,280	-132,714	-187,402	-328,812	-48,635
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	206,641	205,036	279,626	244,112	409,924
Capital Expenditures	-61,177	-61,411	-72,866	-71,239	-74,258
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-20,564	-36,901	-46,061	-74,755	36,968
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-81,741	-98,312	-118,927	-145,994	-37,290
Financing Cash Flow Items	-2,351	-33	-47	-58	-81
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-66,872	-99,497	-107,408	-145,641	-139,331
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	57,081	8,393	55,419	-45,584	236,505